Log in to save to my catalogue

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2077456098

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

About this item

Full title

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018-07, Vol.13 (7), p.e0201314-e0201314

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The expression of Sialyl-Tn (STn) in tumors is associated with metastatic disease, poor prognosis, and reduced overall survival. STn is expressed on ovarian cancer biomarkers including CA-125 (MUC16) and MUC1, and elevated serum levels of STn in ovarian cancer patients correlate with lower five-year survival rates. In the current study, we humanize...

Alternative Titles

Full title

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2077456098

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2077456098

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0201314

How to access this item